acrolein has been researched along with Heart Disease, Ischemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, L; Han, X; Li, L; Liu, Y; Qi, J; Qu, W; Yang, Y; Zheng, B | 1 |
| Li, H; Song, F; Sun, J; Wang, S | 1 |
2 other study(ies) available for acrolein and Heart Disease, Ischemic
| Article | Year |
|---|---|
Mechanisms of cinnamic aldehyde against myocardial ischemia/hypoxia injury in vivo and in vitro: Involvement of regulating PI3K/AKT signaling pathway.
Topics: Acrolein; Animals; Animals, Outbred Strains; Apoptosis; Cell Line; Creatine Kinase; Dose-Response Relationship, Drug; L-Lactate Dehydrogenase; Male; Mice; Myocardial Ischemia; Myocardial Reperfusion Injury; Oxidative Stress; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Random Allocation | 2022 |
Protective effects of cinnamic acid and cinnamic aldehyde on isoproterenol-induced acute myocardial ischemia in rats.
Topics: Acrolein; Animals; Cardiotonic Agents; Cinnamates; Creatine Kinase, MB Form; Interleukin-6; Isoproterenol; L-Lactate Dehydrogenase; Male; Myocardial Ischemia; Myocardium; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2013 |